ABCL
Price:
$2.39
Market Cap:
$704.25M
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.[Read more]
Industry
Biotechnology
IPO Date
2020-12-11
Stock Exchange
NASDAQ
Ticker
ABCL
According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 602.99M. This represents a change of -49.56% compared to the average of 1.20B of the last 4 quarters.
The mean historical Enterprise Value of AbCellera Biologics Inc. over the last ten years is 5.86B. The current 602.99M Enterprise Value has changed 929.27% with respect to the historical average. Over the past ten years (40 quarters), ABCL's Enterprise Value was at its highest in in the September 2020 quarter at 15.58B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
5.86B
Median
3.50B
Minimum
0
Maximum
13.99B
Discovering the peaks and valleys of AbCellera Biologics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 13.99B
Minimum Annual Increase = -65.84%
Minimum Annual Enterprise Value = 0
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.60B | -38.25% |
2022 | 2.58B | -26.27% |
2021 | 3.50B | -65.84% |
2020 | 10.26B | 13.02% |
2019 | 9.08B | -35.15% |
2018 | 13.99B | Infinity% |
The current Enterprise Value of AbCellera Biologics Inc. (ABCL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.56B
5-year avg
5.40B
10-year avg
5.86B
AbCellera Biologics Inc.’s Enterprise Value is greater than CohBar, Inc. (-4942363.00), greater than Hepion Pharmaceuticals, Inc. (2.24M), greater than Rain Therapeutics Inc. (7.16M), less than Krystal Biotech, Inc. (4.95B), greater than AVROBIO, Inc. (-85302404.00), greater than CureVac N.V. (390.67M), less than Reata Pharmaceuticals, Inc. (6.68B), less than Vir Biotechnology, Inc. (864.03M), greater than Propanc Biopharma, Inc. (1.07M), less than PTC Therapeutics, Inc. (2.17B), less than Sarepta Therapeutics, Inc. (13.28B), less than Iovance Biotherapeutics, Inc. (2.89B), less than Madrigal Pharmaceuticals, Inc. (4.91B),
Company | Enterprise Value | Market cap |
---|---|---|
-4942363.00 | $1.25M | |
2.24M | $4.20M | |
7.16M | $44.01M | |
4.95B | $5.29B | |
-85302404.00 | $5.24M | |
390.67M | $614.60M | |
6.68B | $6.57B | |
864.03M | $1.06B | |
1.07M | $278.87K | |
2.17B | $2.43B | |
13.28B | $12.29B | |
2.89B | $3.04B | |
4.91B | $5.30B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AbCellera Biologics Inc.'s Enterprise Value?
What is the highest Enterprise Value for AbCellera Biologics Inc. (ABCL)?
What is the 3-year average Enterprise Value for AbCellera Biologics Inc. (ABCL)?
What is the 5-year average Enterprise Value for AbCellera Biologics Inc. (ABCL)?
How does the current Enterprise Value for AbCellera Biologics Inc. (ABCL) compare to its historical average?